Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Teva and Aurinia settle generics dispute over lupus drug, voclosporin
3+ day, 13+ hour ago (94+ words) Life Sciences IP Review - Teva and Aurinia settle generics dispute over lupus drug, voclosporin Under the terms of the agreement, which resolves all patent litigation between the biopharma rivals, Teva now has a launch date for its own version of…...
SK Biopharmaceuticals settles epilepsy generic dispute
4+ day, 19+ hour ago (85+ words) Life Sciences IP Review SK Biopharmaceuticals settles epilepsy generic dispute A reported deal with an Indian manufacturer could clear a path for a future generic launch as the Korean drugmaker leverages one of its biggest US products. To request a…...
10x Genomics dealt major blow in sequencing fight
4+ day, 19+ hour ago (81+ words) Life Sciences IP Review - 10x Genomics dealt major blow in sequencing fight Three disputed sequencing patents took the spotlight as the Federal Circuit weighed challenges to a trio of PTAB rulings. To request a FREE 2-week trial subscription, please signup. For…...
Vanda revives challenge over braille-free label on generic sleep disorder drug
5+ day, 15+ hour ago (92+ words) Life Sciences IP Review - Vanda revives challenge over braille-free label on generic sleep disorder drug Questions over braille on a generic sleep disorder drug label will face fresh scrutiny after an appeals court found fault with the FDA’s approach. To…...
Abbott fends off Chinese rival’s patent challenge at UPC
6+ day, 13+ hour ago (84+ words) Life Sciences IP Review - Abbott fends off Chinese rival’s patent challenge at UPC The European court has backed Abbott in a dispute over glucose-monitoring technology, while offering guidance on a key added-matter issue. To request a FREE 2-week trial subscription,…...
Former head of litigation at Nokia returns to Bird & Bird
6+ day, 21+ hour ago (83+ words) Life Sciences IP Review - Former head of litigation at Nokia returns to Bird & Bird The new partner counts pharmaceuticals and life sciences among his specialisms and previously worked in-house at Sandoz. To request a FREE 2-week trial subscription, please signup....
Europe’s missing biotech bridge: Why IP ownership matters more than capital access
1+ week, 7+ hour ago (108+ words) Life Sciences IP Review - Europe’s missing biotech bridge: Why IP ownership matters more than capital access Europe’s biotechnology challenge is not only whether it can fund innovation. It is whether it can continue to originate and control the foundational IP…...
Novartis scores UK win in high-stakes Entresto fight
1+ week, 3+ day ago (90+ words) Life Sciences IP Review - Novartis scores UK win in high-stakes Entresto fight Pressure for generic manufacturers of the blockbuster heart drug Entresto is mounting as the Swiss pharma company secures a win over a challenge to its UK patent protection....
Invisalign maker secures first China win against clear aligner rival
1+ week, 4+ day ago (88+ words) Life Sciences IP Review - Invisalign maker secures first China win against clear aligner rival Clear aligner rivals are fighting over orthodontic technology across several major markets and the latest development in China has raised the stakes. To request a FREE…...
Holland & Hart adds high-stakes patent litigation team from Ashurst Perkins Coie
1+ week, 4+ day ago (96+ words) Life Sciences IP Review - Holland & Hart adds high-stakes patent litigation team from Ashurst Perkins Coie Less than a month after the merger between Ashurst and Perkins Coie, the new team brings expertise in high-stakes patent matters—including medtech and biotech…...